Release Date: 30/04/12 09:09 Summary: March Quarter Activities Report Price Sensitive: Yes Download Document 1.25MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%